Risk and outcomes of coronavirus disease in patients with inflammatory bowel disease: A systematic review and meta-analysis.

ABSTRACT:

Background

The risk of severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) infection and clinical outcomes of coronavirus disease (COVID-19) in inflammatory bowel disease are unclear.

Methods

We searched PubMed and Embase with the keywords: inflammatory bowel disease, Crohn's disease, ulcerative colitis and COVID-19, novel coronavirus and SARS-CoV-2. We included studies reporting the frequency of COVID-19 infection and outcomes (hospitalisation, need for intensive care unit care and mortality) in patients with inflammatory bowel disease. We estimated the pooled incidence of COVID-19 in inflammatory bowel disease and comparative risk vis-a-vis the general population. We also estimated the pooled frequency of outcomes and compared them in patients who received

SUBMITTER: Singh AK 

PROVIDER: S-EPMC8250629 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature